33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • LIO-1: Lucitanib + nivolumab in patients with advanced solid tumors - Updated phase 1b results and initial experience in phase 2 ovarian cancer cohort
    Meeting Abstract

    Hamilton, E. P.; Jackson, C. C.; Eskander, R. N.; Backes, F. J.; Makker, V.; Musa, F.; Olawaiye, A.; Alldredge, J.; Pothuri, B.; Secord, A. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405
    Meeting Abstract

    DiNardo, K.; Ma, C.; Ou, F. S.; Yuan, C.; Guercio, B. J.; Morales-Oyarvide, V.; Van Blarigan, E.; Niedzwiecki, D.; Chang, I. W.; Lenz, H. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Avelumab in patients with previously treated Merkel cell carcinoma (JAVELIN Merkel 200): Updated overall survival data after more than five years of follow up
    Meeting Abstract

    Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbe, C.; Lewis, K. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy and safety data from CheckMate 649
    Meeting Abstract

    Moehler, M. H.; Shitara, K.; Garrido, M.; Salman, P.; Shen, L.; Wyrwicz, L.; Yamaguchi, K.; Skoczylas, T.; Bragagnoli, A. S. C.; Liu, T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): Depth of response and efficacy for selected subgroups in the lenvatinib (LEN) + pembrolizumab (PEMBRO) and sunitinib (SUN) treatment arms
    Meeting Abstract

    Grünwald, V.; Powles, T.; Kopyltsov, E.; Kozlov, V.; Gordoa, T. A.; Eto, M.; Hutson, T. E.; Motzer, R. J.; Winquist, E.; Maroto-Rey, P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Trial in progress: A phase 1b study of sotorasib, a specific and irreversible KRAS(G12C) inhibitor, as monotherapy in non-small cell lung cancer (NSCLC) with brain metastasis and in combination with other anticancer therapies in advanced solid tumors (CodeBreaK 101)
    Meeting Abstract

    Hong, D. S.; Strickler, J. H.; Fakih, M.; Falchook, G. S.; Li, B. T.; Durm, G. A.; Burns, T. F.; Ramalingam, S. S.; Goldberg, S. B.; Frank, R. C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • DREAM3R: Durvalumab with chemotherapy as firstline treatment in advanced pleural mesothelioma - A phase 3 randomized trial
    Meeting Abstract

    Forde, P. M.; Nowak, A. K.; Kok, P. S.; Brown, C.; Sun, Z.; Anagnostou, V.; O'Byrne, K. J.; Yip, S.; Cook, A.; Lesterhuis, W. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Assessment of HER2 (ERBB2) amplification (HER2amp) using blood-based circulating tumor DNA (ctDNA) next generation sequencing (NGS) and correlation with tissue-based testing in metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Raghav, K. P. S.; Nakamura, Y.; Marsoni, S.; Strickler, J. H.; Yaeger, R.; Shah, A. T.; Okamoto, W.; Crisafulli, G.; Nagy, R.; Raymond, V. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Integration of a polygenic risk score of kidney function with cumulative cisplatin dose and time variables for the prediction of serum platinum levels
    Meeting Abstract

    Shuey, M.; Faucon, A.; Trendowski, M. R.; Ratain, M. J.; Dinh, P. C.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Fung, C.; Kollmannsberger, C. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Evaluation of pharmacodynamic (PD) and biologic activity in a preoperative window-of-opportunity (WOO) study of giredestrant (GDC-9545) in postmenopausal patients (pts) with estrogen receptor-positive, HER2-negative (ER+/HER2-) operable breast cancer (BC)
    Meeting Abstract

    Moore, H. M.; Boni, V.; Bellet, M.; De Las Heras, B. B.; Cortés, M. G.; Oakman, C.; Schmid, P.; Trinh, X. B.; Wheatley, D.; Jhaveri, K. L.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save